Nasdaq-listed technology investor Acacia Research Corporation has acquired an 11.8% stake in UK-based clinical AI company Sensyne Health. Precise terms of the deal have not been disclosed, but it forms part of an agreement to purchase shares in up to 19 public and private life sciences companies from LF Equity Income Fund for £223.9m. Founded…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
